GlassScriptPhysician profile
Laurence Leon Dennis
NPI 1760466262
$3,742.13
in general payments reported to CMS, 2019-2025
41 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $599 · 2021: $763 · 2022: $535 · 2023: $338 · 2024: $393 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $631.82 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $527.50 | 2019-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $289.11 | 2019-2024 | |
| Alpha Cognition USA, INC. | $223.29 | 2025 | Zunveyl |
| Sunovion Pharmaceuticals INC. | $174.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $173.60 | 2020-2025 | Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.60 | 2020-2022 | |
| Novo Nordisk INC | $154.99 | 2020-2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $139.28 | 2021 | |
| Abbvie INC. | $126.87 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.16 | 2022-2025 | |
| Lilly USA, LLC | $103.15 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $101.52 | 2019-2023 | Eliquis |
| Teva Pharmaceuticals USA, INC. | $82.98 | 2020-2023 | Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $66.05 | 2019-2021 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.